Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2002 Dec;57(12):1040–1044. doi: 10.1136/thorax.57.12.1040

Randomised pragmatic comparison of UK and US treatment of acute asthma presenting to hospital

N Innes 1, J Stocking 1, T Daynes 1, B Harrison 1
PMCID: PMC1758800  PMID: 12454298

Abstract

Background: Systemic corticosteroids and inhaled ß2 agonists are accepted first line treatments for acute severe asthma, but there is no consensus on their optimum dosage and frequency of administration. American regimens include higher initial dosages of ß2 agonists and corticosteroids than UK regimens.

Methods: In a prospective, pragmatic, randomised, parallel group study, 170 patients of mean (SD) age 37 (12) years with acute asthma (peak expiratory flow (PEF) 212 (80) l/min) presenting to hospital received treatment with either high dose prednisolone and continuous nebulised salbutamol as recommended in the US or lower dose prednisolone and bolus nebulised salbutamol as recommended in the UK by the BTS.

Results: Outcome measures were: ΔPEF at 1 hour (BTS 89 l/min, US 106 l/min, p=0.2, CI –8 to 41) and at 2 hours (BTS 49 l/min, US 101 l/min, p<0.0001, CI 28 to 77); time to discharge if admitted (BTS 4 days, US 4 days); rates of achieving discharge PEF (>60%) at 2 hours (BTS 64%, US 78%, p=0.04); time to regain control of asthma as measured by PEF ≥80% best with ≤20% variability (BTS 3 days, US 4 days, p=0.6); PEF at 24 hours in patients admitted (BTS 293 l/min, US 288 l/min, p=0.8); and control of asthma in the subsequent month (no significant differences).

Conclusions: Treatment with higher doses of continuous nebulised salbutamol leads to a greater immediate improvement in PEF but the degree of recovery at 24 hours and speed of recovery thereafter is achieved as effectively with lower corticosteroid doses as recommended in the British guidelines.

Full Text

The Full Text of this article is available as a PDF (157.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman D. G. Statistics and ethics in medical research: III How large a sample? Br Med J. 1980 Nov 15;281(6251):1336–1338. doi: 10.1136/bmj.281.6251.1336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bowler S. D., Mitchell C. A., Armstrong J. G. Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax. 1992 Aug;47(8):584–587. doi: 10.1136/thx.47.8.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Britton J., Tattersfield A. Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma. Thorax. 1984 Aug;39(8):597–599. doi: 10.1136/thx.39.8.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Britton M. G., Collins J. V., Brown D., Fairhurst N. P., Lambert R. G. High-dose corticosteroids in severe acute asthma. Br Med J. 1976 Jul 10;2(6027):73–74. doi: 10.1136/bmj.2.6027.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Colacone A., Wolkove N., Stern E., Afilalo M., Rosenthal T. M., Kreisman H. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest. 1990 Mar;97(3):693–697. doi: 10.1378/chest.97.3.693. [DOI] [PubMed] [Google Scholar]
  6. Davis M., Williams R., Chakraborty J., English J., Marks V., Ideo G., Tempini S. Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability. Br J Clin Pharmacol. 1978 Jun;5(6):501–505. doi: 10.1111/j.1365-2125.1978.tb01664.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Engel T., Dirksen A., Frølund L., Heinig J. H., Svendsen U. G., Pedersen B. K., Weeke B. Methylprednisolone pulse therapy in acute severe asthma. A randomized, double-blind study. Allergy. 1990 Apr;45(3):224–230. doi: 10.1111/j.1398-9995.1990.tb00487.x. [DOI] [PubMed] [Google Scholar]
  8. Fanta C. H., Rossing T. H., McFadden E. R., Jr Glucocorticoids in acute asthma. A critical controlled trial. Am J Med. 1983 May;74(5):845–851. doi: 10.1016/0002-9343(83)91076-8. [DOI] [PubMed] [Google Scholar]
  9. Harfi H., Hanissian A. S., Crawford L. V. Treatment of status asthmaticus in children with high doses and conventional doses of methylprednisolone. Pediatrics. 1978 Jun;61(6):829–831. [PubMed] [Google Scholar]
  10. Harrison B. D., Stokes T. C., Hart G. J., Vaughan D. A., Ali N. J., Robinson A. A. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet. 1986 Jan 25;1(8474):181–184. doi: 10.1016/s0140-6736(86)90654-9. [DOI] [PubMed] [Google Scholar]
  11. Heimer D., Shim C., Williams M. H., Jr The effect of sequential inhalations of metaproterenol aerosol in asthma. J Allergy Clin Immunol. 1980 Jul;66(1):75–77. doi: 10.1016/0091-6749(80)90141-4. [DOI] [PubMed] [Google Scholar]
  12. Lin R. Y., Pesola G. R., Westfal R. E., Bakalchuk L., Freyberg C. W., Cataquet D., Heyl G. T. Early parenteral corticosteroid administration in acute asthma. Am J Emerg Med. 1997 Nov;15(7):621–625. doi: 10.1016/s0735-6757(97)90172-8. [DOI] [PubMed] [Google Scholar]
  13. Lin R. Y., Sauter D., Newman T., Sirleaf J., Walters J., Tavakol M. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med. 1993 Dec;22(12):1847–1853. doi: 10.1016/s0196-0644(05)80412-3. [DOI] [PubMed] [Google Scholar]
  14. Littenberg B., Gluck E. H. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986 Jan 16;314(3):150–152. doi: 10.1056/NEJM198601163140304. [DOI] [PubMed] [Google Scholar]
  15. Luksza A. R. Acute severe asthma treated without steroids. Br J Dis Chest. 1982 Jan;76(1):15–19. [PubMed] [Google Scholar]
  16. McFadden E. R., Jr Dosages of corticosteroids in asthma. Am Rev Respir Dis. 1993 May;147(5):1306–1310. doi: 10.1164/ajrccm/147.5.1306. [DOI] [PubMed] [Google Scholar]
  17. McFadden E. R., Jr, Elsanadi N., Dixon L., Takacs M., Deal E. C., Boyd K. K., Idemoto B. K., Broseman L. A., Panuska J., Hammons T. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med. 1995 Dec;99(6):651–661. doi: 10.1016/s0002-9343(99)80253-8. [DOI] [PubMed] [Google Scholar]
  18. McFadden E. R., Jr, Kiser R., deGroot W. J., Holmes B., Kiker R., Viser G. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am J Med. 1976 Jan;60(1):52–59. doi: 10.1016/0002-9343(76)90533-7. [DOI] [PubMed] [Google Scholar]
  19. Morell F., Orriols R., de Gracia J., Curull V., Pujol A. Controlled trial of intravenous corticosteroids in severe acute asthma. Thorax. 1992 Aug;47(8):588–591. doi: 10.1136/thx.47.8.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Papo M. C., Frank J., Thompson A. E. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993 Oct;21(10):1479–1486. doi: 10.1097/00003246-199310000-00015. [DOI] [PubMed] [Google Scholar]
  21. Raimondi A. C., Figueroa-Casas J. C., Roncoroni A. J. Comparison between high and moderate doses of hydrocortisone in the treatment of status asthmaticus. Chest. 1986 Jun;89(6):832–835. doi: 10.1378/chest.89.6.832. [DOI] [PubMed] [Google Scholar]
  22. Ratto D., Alfaro C., Sipsey J., Glovsky M. M., Sharma O. P. Are intravenous corticosteroids required in status asthmaticus? JAMA. 1988 Jul 22;260(4):527–529. [PubMed] [Google Scholar]
  23. Reisner C., Kotch A., Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study. Ann Allergy Asthma Immunol. 1995 Jul;75(1):41–47. [PubMed] [Google Scholar]
  24. Robertson C. F., Smith F., Beck R., Levison H. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr. 1985 Apr;106(4):672–674. doi: 10.1016/s0022-3476(85)80101-3. [DOI] [PubMed] [Google Scholar]
  25. Rodrigo C., Rodrigo G. Early administration of hydrocortisone in the emergency room treatment of acute asthma: a controlled clinical trial. Respir Med. 1994 Nov;88(10):755–761. doi: 10.1016/s0954-6111(05)80198-2. [DOI] [PubMed] [Google Scholar]
  26. Rudnitsky G. S., Eberlein R. S., Schoffstall J. M., Mazur J. E., Spivey W. H. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med. 1993 Dec;22(12):1842–1846. doi: 10.1016/s0196-0644(05)80411-1. [DOI] [PubMed] [Google Scholar]
  27. Shrestha M., Bidadi K., Gourlay S., Hayes J. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest. 1996 Jul;110(1):42–47. doi: 10.1378/chest.110.1.42. [DOI] [PubMed] [Google Scholar]
  28. Stein L. M., Cole R. P. Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med. 1990 Jun 1;112(11):822–827. doi: 10.7326/0003-4819-112-11-822. [DOI] [PubMed] [Google Scholar]
  29. Tanaka R. M., Santiago S. M., Kuhn G. J., Williams R. E., Klaustermeyer W. B. Intravenous methylprednisolone in adults in status asthmaticus. Comparison of two dosages. Chest. 1982 Oct;82(4):438–440. doi: 10.1378/chest.82.4.438. [DOI] [PubMed] [Google Scholar]
  30. Webb J. R. Dose response of patients to oral corticosteroid treatment during exacerbations of asthma. Br Med J (Clin Res Ed) 1986 Apr 19;292(6527):1045–1047. doi: 10.1136/bmj.292.6527.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES